Skip to main content

Want a detailed portfolio tracker?

Qualigen Therapeutics, Inc. Common Stock (QLGN) P/E (2025 - 2026)

Qualigen Therapeutics, Inc. Common Stock (QLGN) P/E from Mar 31, 2025 to Jul 21, 2026. The TTM Qualigen Therapeutics, Inc. Common Stock (QLGN) P/E is -0.28. You can export chart.

P/E

Annual P/E change of Qualigen Therapeutics, Inc. Common Stock (QLGN)

YearP/EChange
2026-0.28-66.79%
2025-0.83N/A

Comparison Qualigen Therapeutics, Inc. Common Stock (QLGN) P/E with competitors

Qualigen Therapeutics, Inc. Common Stock (QLGN) P/E is -0.28.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.62%
NBYStablecoin Development Corp0.00-101.56%
ENLVEnlivex Ltd0.07-127.17%
FGENFibroGen Inc0.24-187.19%
CHRSCoherus Biosciences Inc0.85-408.22%
FBIOFortress Biotech Inc0.95-444.72%
ORMPOramed Pharmaceuticals Inc1.50-645.96%
AGENAgenus Inc3.01-1193.19%
INVAInnoviva Inc3.15-1245.65%
VXRTVaxart Inc3.55-1389.38%
CRMDCorMedix Inc3.63-1417.97%
CVACCureVac N.V.4.45-1714.82%
GLPGGalapagos NV4.86-1864.91%
SRPTSarepta Therapeutics Inc4.88-1873.34%
ABEOAbeona Therapeutics Inc5.39-2056.92%
ABUSArbutus Biopharma Corp5.60-2132.52%
ZVRAZevra Therapeutics Inc5.89-2238.44%
SPROSpero Therapeutics Inc6.23-2362.38%
CGENCompugen Ltd6.31-2393.44%
RIGLRigel Pharmaceuticals6.87-2596.16%
SLXNSilexion Therapeutics Corp7.30-2750.18%
OMEROmeros Corporation9.26-3463.09%
AUPHAurinia Pharmaceuticals Inc9.58-3581.58%
PLXProtalix BioTherapeutics Inc10.89-4055.98%
ACADAcadia Pharmaceuticals Inc11.73-4360.20%
TBPHTheravance Biopharma Inc12.26-4554.03%
ADMAAdma Biologics Inc12.42-4610.70%
HRMYHarmony Biosciences Holdings Inc13.82-5119.97%
SABSSAB Biotherapeutics Inc14.14-5234.76%
NAGENiagen Bioscience Inc14.82-5482.46%
INCYIncyte Corp15.82-5847.30%
REGNRegeneron Pharmaceuticals Inc15.86-5859.69%
PBYIPuma Biotechnology Inc17.32-6389.67%
CPRXCatalyst Pharmaceuticals Inc17.44-6434.57%
EXELExelixis Inc17.54-6470.42%
TGTXTG Therapeutics Inc18.97-6989.14%
MDXGMimedx Group Inc20.55-7565.39%
XOMAXOMA Royalty Corp22.87-8409.11%
ARGXArgen X SE24.30-8926.12%
CTMXCytomX Therapeutics Inc24.82-9116.13%
XOMAOXOMA Royalty Corp25.34-9306.36%
HALOHalozyme Therapeutics Inc25.62-9407.67%
XOMAPXOMA Royalty Corp25.67-9424.53%
VRTXVertex Pharmaceuticals Inc27.99-10268.93%
RPRXRoyalty Pharma plc - Class A28.69-10520.59%
SLNOSoleno Therapeutics Inc29.02-10639.66%
ASNDAscendis Pharma A/S30.09-11028.41%
LGNDLigand Pharmaceuticals Inc - Class B37.91-13871.33%
APLSApellis Pharmaceuticals Inc39.02-14274.25%
BMRNBiomarin Pharmaceutical Inc42.21-15433.22%
KRYSKrystal Biotech Inc45.34-16570.77%
ONCBeiGene Ltd69.54-25360.20%
PHARPharming Group N.V.75.03-27352.65%
TECHBio-Techne Corp101.96-37135.85%
VCELVericel Corp109.92-40028.35%
ALNYAlnylam Pharmaceuticals Inc117.96-42950.21%
GMABGenmab140.29-51059.89%
TLXTelix Pharmaceuticals Ltd162.15-59001.17%
CORTCorcept Therapeutics Inc212.86-77419.38%